Lisata Therapeutics, Inc. Common Stock
$1.54
-$0.02 (-1.28%)
$1.43Day Range$1.56
Key Statistics
Market Cap
$13.88M
Shares Outstanding
9.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 1, 1999
Round Lot
100
Locale
US
Trading Data
Day Open
$1.53
Day High
$1.56
Day Low
$1.43
Volume
157.9K
VWAP
$1.49
Prev Close
$1.56
Transactions
--
Acc. Volume
--
About Lisata Therapeutics, Inc. Common Stock
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
PHARMACEUTICAL PREPARATIONSSIC 283421 employees110 ALLEN ROAD, BASKING RIDGE, NJ, 07920908-229-2590IPO Mar 1, 1999US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000320017
- Composite FIGI
- BBG000BNVDR4
- Share Class FIGI
- BBG001SBTRW6
- Ticker Root
- LSTA
- SIC Code
- 2834
About Lisata Therapeutics, Inc. Common Stock (LSTA) Stock
Lisata Therapeutics, Inc. Common Stock (LSTA) closed the 2026-09-15 session at $1.54, down 1.28% versus the previous close (-0.02). The stock opened at $1.53 and traded between $1.43 and $1.56 during that session. Session trading volume was 158K shares. The volume-weighted average price (VWAP) is $1.49.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Lisata Therapeutics, Inc. Common Stock has a market capitalization of $13.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. LSTA is listed on the XNAS exchange. The company employs approximately 21 people. Lisata Therapeutics, Inc. Common Stock is headquartered in BASKING RIDGE, NJ. The recorded listing date is 1999-03-01.
On this page you can find market LSTA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.